Martin Henkes

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

F. La Rosée, Hinrich Bremer, Iris Gehrke et al. · Leukemia · 2020 · 243 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Martin Henkes, Heiko van der Kuip, Walter E. Aulitzky · PubMed · 2008 · 49 citations · Full text

Medicine, Oncology, Pharmacology +11

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal

T. Albrecht, Renate Schwab, Martin Henkes et al. · British Journal of Haematology · 1996 · 46 citations

Medicine, Cell Biology, Hematology +17

Evidence for a diagnostic window in fourth generation assays for HIV

Thomas Meier, E. Knoll, Martin Henkes et al. · Journal of Clinical Virology · 2001 · 35 citations

Life Sciences, Infectious Diseases, Microbiology +14

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation

Martin Henkes, Sonja Martin, H. Einsele et al. · Annals of Hematology · 2002 · 13 citations

Medicine, Hematology, Immunology +17